MXPA03007123A - Formas cristalinas de derivado de nucleosido de pirimidina. - Google Patents

Formas cristalinas de derivado de nucleosido de pirimidina.

Info

Publication number
MXPA03007123A
MXPA03007123A MXPA03007123A MXPA03007123A MXPA03007123A MX PA03007123 A MXPA03007123 A MX PA03007123A MX PA03007123 A MXPA03007123 A MX PA03007123A MX PA03007123 A MXPA03007123 A MX PA03007123A MX PA03007123 A MXPA03007123 A MX PA03007123A
Authority
MX
Mexico
Prior art keywords
crystal
pyrimidine nucleoside
nucleoside derivative
crystalline forms
derivative
Prior art date
Application number
MXPA03007123A
Other languages
English (en)
Inventor
Takashi Takita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of MXPA03007123A publication Critical patent/MXPA03007123A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
MXPA03007123A 2001-02-09 2002-02-06 Formas cristalinas de derivado de nucleosido de pirimidina. MXPA03007123A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001033128 2001-02-09
PCT/JP2002/000986 WO2002064609A1 (fr) 2001-02-09 2002-02-06 Cristaux de derive de nucleoside de pyrimidine

Publications (1)

Publication Number Publication Date
MXPA03007123A true MXPA03007123A (es) 2003-11-18

Family

ID=18896929

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007123A MXPA03007123A (es) 2001-02-09 2002-02-06 Formas cristalinas de derivado de nucleosido de pirimidina.

Country Status (21)

Country Link
EP (1) EP1364959B1 (es)
JP (2) JP3748536B2 (es)
KR (1) KR100679904B1 (es)
CN (1) CN100408591C (es)
AT (1) ATE361929T1 (es)
AU (1) AU2002230164B2 (es)
BR (2) BRPI0207102A8 (es)
CA (1) CA2437994C (es)
CY (1) CY1106685T1 (es)
CZ (1) CZ303241B6 (es)
DE (1) DE60220024T2 (es)
DK (1) DK1364959T3 (es)
ES (1) ES2286237T3 (es)
HU (1) HU229294B1 (es)
IL (2) IL157216A0 (es)
MX (1) MXPA03007123A (es)
NZ (1) NZ527393A (es)
PT (1) PT1364959E (es)
RU (1) RU2256666C2 (es)
WO (1) WO2002064609A1 (es)
ZA (1) ZA200306121B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101232779B (zh) 1999-09-02 2013-03-27 揖斐电株式会社 印刷布线板
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
GB0625283D0 (en) 2006-12-19 2007-01-24 Cyclacel Ltd Combination
JP5066737B2 (ja) * 2007-04-06 2012-11-07 大鵬薬品工業株式会社 シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤
US8124593B2 (en) 2007-11-05 2012-02-28 Cyclacel Limited Methods of treatment using sapacitabine
GB0808357D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
WO2009150405A1 (en) 2008-06-09 2009-12-17 Cyclacel Limited Combination of spacitabine (cndac) and dna methyltransferase inhibitors such as decitabine and procaine
EP2696878B1 (en) 2011-04-14 2019-07-10 Cyclacel Limited Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia
KR102081042B1 (ko) * 2012-03-15 2020-02-26 셀젠 카르 엘엘씨 상피 성장 인자 수용체 키나제 억제제의 고체 형태
FI3268379T3 (fi) * 2015-03-09 2023-12-15 Grace W R & Co Nikotiiniamidiribosidin kiteinen muoto
CA3086535A1 (en) 2017-12-22 2019-06-27 Elysium Health, Inc. Crystalline forms of nicotinamide riboside chloride

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI105556B (fi) * 1991-09-30 2000-09-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta

Also Published As

Publication number Publication date
DK1364959T3 (da) 2007-06-04
BR0207102A (pt) 2004-01-27
IL157216A0 (en) 2004-02-19
JP2006008699A (ja) 2006-01-12
CZ303241B6 (cs) 2012-06-13
CN1501939A (zh) 2004-06-02
DE60220024T2 (de) 2007-11-22
KR20030081424A (ko) 2003-10-17
JP4356998B2 (ja) 2009-11-04
CY1106685T1 (el) 2012-05-23
NZ527393A (en) 2004-07-30
CA2437994C (en) 2011-05-17
JP3748536B2 (ja) 2006-02-22
PT1364959E (pt) 2007-07-23
EP1364959B1 (en) 2007-05-09
DE60220024D1 (en) 2007-06-21
ZA200306121B (en) 2005-01-26
ATE361929T1 (de) 2007-06-15
JP2002308895A (ja) 2002-10-23
HUP0303159A3 (en) 2007-06-28
AU2002230164B2 (en) 2005-04-07
CZ20032111A3 (cs) 2003-12-17
WO2002064609A1 (fr) 2002-08-22
KR100679904B1 (ko) 2007-02-07
CA2437994A1 (en) 2002-08-22
HUP0303159A2 (hu) 2003-12-29
CN100408591C (zh) 2008-08-06
HU229294B1 (en) 2013-10-28
BRPI0207102A8 (pt) 2018-02-27
ES2286237T3 (es) 2007-12-01
EP1364959A1 (en) 2003-11-26
RU2003124648A (ru) 2005-02-27
IL157216A (en) 2008-03-20
RU2256666C2 (ru) 2005-07-20
EP1364959A4 (en) 2004-03-24

Similar Documents

Publication Publication Date Title
CY1106685T1 (el) Κρυσταλλος παραγωγου πυριμιδινο νουκλεοζιτη
IL160872A0 (en) Pyrimidinones as melanin concentrating hormone receptor 1
PT1448853E (pt) Melhoramentos relacionados com branqueadores ópticos
IL159418A0 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
WO2001019828A3 (en) Kinase inhibitors as therapeutic agents
MA28172A1 (fr) 5,7-diaminopyrazolo [4,3-D] pyrimidines à activité inhibitrice de PDE-5
WO2004046118A3 (en) 2-4-(di-phenyl-amino)-pyrimidine derivatives useful for treating hyper-proliferative disorders
CY1111759T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη συγκεκριμενων τριαζολοπυριμιδινων ως ρ2τ ανταγωνιστων
BR0210030A (pt) Derivado de fenilpiridinacarbonilpiperazina
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
HK1069395A1 (en) Phthalazinone derivatives 2,3
CY1106132T1 (el) Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου
WO2004035569A3 (de) Neue verbindungen mit antibakterieller aktivität
DK1442024T3 (da) Aminobenzamidderivater som glycogensystasekinase 3 beta-inhibitorer
AU2001277753A1 (en) Phosphonocephem compound
HK1088013A1 (en) Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
MXPA02004440A (es) Derivados de pirrol como inhibidores de la fosfodiesterasa vii.
SE0103710D0 (sv) Compounds
MXPA03009602A (es) Analogos de nociceptina.
CA2452036A1 (en) 6-'2-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
DOP2002000371A (es) Fenil-heterociclil-eteres
GB0215392D0 (en) Chemical compounds
HK1064673A1 (en) Fused-polycyclic compounds
ES2185599T3 (es) Preparacion de intermediarios de la imidazodiacepina.
MXPA04003085A (es) Proceso estereoespecifico para sintesis de derivados de 2-il cromano.

Legal Events

Date Code Title Description
FG Grant or registration